¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
º¸°í¼ ¸ÞŸµ¥ÀÌÅÍ
- Áö¸®Àû ¹üÀ§ : ¶óƾ¾Æ¸Þ¸®Ä«(ºê¶óÁú, ¸ß½ÃÄÚ, Ä¥·¹, ÄÝ·Òºñ¾Æ, ¾Æ¸£ÇîÆ¼³ª, Æä·ç, Áß¹Ì, Ä«¸®ºêÇØ ±¹°¡ µî).
- ÁÖ¿ä ¼öÄ¡(¶óƾ¾Æ¸Þ¸®Ä«) : 1¾ï 2,000¸¸ ´Þ·¯(2023³â) ¡æ 10¾ï ´Þ·¯(2032³â), CAGR-26.6%
- ´ë»ó ºÎ¹® ¾ç½Ä(CT, MRI, X¼± ¹× DR, ÃÊÀ½ÆÄ, PET ¹× ÇÙ ÀÇÇÐ), ÀÓ»ó ºÐ¾ß(Á¾¾çÇÐ, ½Å°æÇÐ/³úÁ¹Áß, ½ÉÀå º´ÇÐ, È£Èí±â ¹× Æó, MSK ¹× Á¤Çü¿Ü°ú, ÀÏ¹Ý Áø´Ü), ¿ëµµ(Á¶±â ¹ß°ß ¹× ºÐ·ù, Áø´Ü Á¤È®µµ, ¿öÅ©ÇÃ·Î¿ì ¹× È¿À², ¿¹ÈÄ ¹× Ä¡·á, ¿µ»ó Çâ»ó ¹× ¿ë·®, ¼¼ºÐÈ ¹× Ư¡ ÃßÃâ, ¸ð´Þ¸®Æ¼ °£ ÅëÇÕ), ¼öÀÍ¿ø(Çϵå¿þ¾î, ¼ÒÇÁÆ®¿þ¾î, ¼ºñ½º, Ŭ¶ó¿ìµå ¹× »ç¿ë´ç ÁöºÒ), ÃÖÁ¾ »ç¿ë(º´¿ø, ¿µ»ó ¼¾ÅÍ, Ŭ¸®´Ð, ¿ø°Ý ¹æ»ç¼±ÇÐ µî).
- ÇÁ·¹ÀÓ¿öÅ© ¹× ºñÁÖ¾ó ¼Ö·ç¼Ç äÅà ¹× ¼ºÀå ¸ÅÆ®¸¯½º, »ýÅÂ°è ¿¬°è ¸ÅÆ®¸¯½º, GTM Áغñ ·¹ÀÌ´õ, GTM ŸÀÓ¶óÀÎ, Ŭ·¯½ºÅÍ ¿ì¼± ¼øÀ§ È÷Æ®¸Ê, ±ÔÁ¦ ¼Óµµ ¹× »óȯ ÆÞ½º, OEM AI ÀåÂø·ü.
- Á¶»ç ¹æ¹ý ¹× ǰÁú º¸Áõ : µà¾ó ·»Áî(ž´Ù¿î ÆÛ³Î + »óÇâ½Ä ºÎÂø ¼Óµµ), Áõ°Å ½Å·Ú¼º ·çºê¸¯, ǰÁú°ü¸® ·çÇÁ(ÃÑ, ½ºÅ©·¡ÇÁ µðÇÁ, ½Å¼±µµ, ASP À§»ý).
¶óƾ¾Æ¸Þ¸®Ä«ÀÇ AI Áö¿ø ÀÇ·á ¿µ»ó ½ÃÀå(Markintel-TM Pulse)Àº ÀÌ Áö¿ª ¼ö¿ä ¡ÈÄ, ±ÔÁ¦ µ¿Çâ, ÀåÂø·üÀÇ °æÁ¦¼ºÀ» ÃßÃâÇÏ¿© ½ÇÇà °¡´ÉÇÑ GTM Ç÷¹À̺ÏÀ» ÀÛ¼ºÇÕ´Ï´Ù. ÀÌ º¸°í¼´Â ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí Áö¿ªº° ÇÁ·¹ÀÓ¿öÅ©, ±¹°¡º° Ŭ·¯½ºÅÍ ¿¹Ãø, ±Ù°Å¿¡ µû¸¥ ±ÇÀå »çÇ×À» ÀÌ¿ëÇÏ¿© ¾îµð¼, ¾î¶»°Ô ÀÌ°Ü¾ß ÇÏ´ÂÁö¸¦ º¸¿©ÁÝ´Ï´Ù.
º» º¸°í¼ÀÇ ´ë»óÀÚ
- CT/MR/X¼± ¹øµé Á¦°ø ¹× ºÎÂø ¼Óµµ Àü·«À» °èȹÇϰí ÀÖ´Â À̹Ì¡ OEM ±â¾÷ .
- ¿£ÅÍÇÁ¶óÀÌÁî ÆÄÀÏ·µ°ú À¯Åë¾÷ü ·çÆ®¸¦ ã´Â AI Ç»¾î Ç÷¹ÀÌ ¹× ¸¶ÄÏÇ÷¹À̽º ÅëÇÕ¾÷ü .
- ¿öÅ©Ç÷οì/QA ¹× Ŭ¶ó¿ìµå OPEX¸¦ ÃÖÀûÈÇÏ´Â ÅÚ·¹¶óµð¿À ·ÎÁö ³×Æ®¿öÅ© ¹× »ç¸³ º´¿ø ±×·ì .
- ¼ºÀå Å׸¶ ¹× ÆÄÆ®³Ê ½ºÅ©¸®´×À» °ËÁõÇÏ´Â ÅõÀÚÀÚ ¹× ±â¾÷ °³¹ß.
- °ø°ø ºÎ¹®ÀÇ ÇÁ·Î±×·¥ ¸®´õ(°áÇÙ, ³úÁ¹Áß, ½ºÅ©¸®´×).
¾òÀ» ¼ö ÀÖ´Â °Í : ¸Þ¸®Æ®
- ÀλçÀÌÆ®¿¡¼ ÇൿÀ¸·ÎÀÇ ¸íÈ®ÇÑ µµ¼± : ÀÌÁß ·»Áî ±â¼ú + QA ·çÇÁ´Â ¸ðµç Ç¥°¡ Áö¿ª ÇÕ°è·Î ±¼·¯°¡°í ¸ðµç ±ÇÀå »çÇ×À» Áõ°Å·Î ¸¸µì´Ï´Ù.
- ¿ì¼±¼øÀ§°¡ ÁöÁ¤µÈ ±¹°¡º° Ŭ·¯½ºÅÍÀÇ ·Îµå¸ÊÀÔ´Ï´Ù .
- ÇÁ·¹ÀÓ¿öÅ© ÁÖµµÀÇ GTM : ¼Ö·ç¼Ç µµÀÔ ¹× ¼ºÀå ¸ÅÆ®¸¯½º¿Í »ýÅÂ°è ¿¬°è ¸ÅÆ®¸¯½º´Â ½ÃÀå ±¸Á¶¸¦ ÆÄÆ®³Ê , °¡°Ý, Àü°³ ¿òÁ÷ÀÓÀ¸·Î º¯È¯ÇÕ´Ï´Ù.
- ¿ÏÀüÇÑ ¼¼ºÐÈ(¸ð´Þ¸®Æ¼, ÀÓ»ó ¿µ¿ª, ¿ëµµ, ¼öÀÍ¿ø, ÃÖÁ¾ ¿ëµµ)°ú 2023-2032³âÀÇ ¿¹Ãø¿¡ ÀÇÇØ »ç³» ÀÚ·á¿¡ÀÇ ½Å¼ÓÇÑ ÀçÀÌ¿ë °¡´É.
º¸°í¼ ³»ºÎ : ¼½¼Çº° ÇÏÀ̶óÀÌÆ®
- ¼½¼Ç 1 : 25ÃÊ ³»¿¡ ÀÐÀ» ¼ö ÀÖ´Â ÁÖ¿ä ¿ä¾à, Áö¿ª ¼öÁØÀÇ KPI, º¯°îÁ¡ ¹× ½Ã¼±, 12°³¿ù ÀÌ»çȸ ¼öÁØÀÇ ¾×¼Ç.
- ¼½¼Ç 2 : Á¶»ç ±â¹ý-¹üÀ§, ¼¼ºÐÈ, µà¾ó ·»Áî ¾ÆÅ°ÅØÃ³, Áõ°Å ½Å·Ú¼º, ǰÁúº¸Áõ .
- ¼½¼Ç 3-4 : ½ÃÀå Ãß°è ¹× ¿¹Ãø-¼ºÀå µå¶óÀ̹ö ¿öÅÍÆú, ÅëÀÏ Å¬·¯½ºÅÍ ¸ðµ¨, Ŭ·¯½ºÅͺ° Ãß°è, ÀÓ»ó ¿µ¿ªº° Ãß°è, ¸ð´Þ¸®Æ¼º° Ãß°è, ¼öÀÍ Ãß°è, ¿ëµµº° Ãß°è, ÃÖÁ¾ ¿ëµµº° Ãß°è.
- ¼½¼Ç 5-7 : GTM µµ±¸-¼Ö·ç¼Ç äÅà ¹× ¼ºÀå ¸ÅÆ®¸¯½º, »ýÅÂ°è ¿¬°è ¸ÅÆ®¸¯½º, 90ÀÏ ¿µ¾÷ ·Îµå¸Ê, GTM Áغñ ·¹ÀÌ´õ, ŸÀÓ¶óÀÎ, ±ÔÁ¦ ¼Óµµ, OEM ÀåÂø·ü, º¥´õ GTM ÇÏÀ̶óÀÌÆ®.
¸ñÂ÷
¼½¼Ç 1-ÁÖ¿ä ¿ä¾à
¼½¼Ç 2-Á¶»ç ±â¹ý
¼½¼Ç 3-¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®
- ½ÃÀå ¿ä¾à
- ¼ºÀå ÃËÁø¿äÀÎ ¿öÅÍÆú-¶óƾ¾Æ¸Þ¸®Ä«
- Áö°æÇРŬ·¯½ºÅÍ(GTM Æ÷Ä¿½º¿ë)
- ºÎ¹® µ¿Çâ(-2032³â)
- ±ÔÁ¦ ½º³À¼¦(ºò5)
- ÃֽŠÁ¤º¸(2024-2025³â)
- Çൿ ÁöÇâ Ãßõ »çÇ×
- »ó¾÷ ½ÅÈ£
¼½¼Ç 4-¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå ÃßÁ¤ ¹× ¿¹Ãø
- ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå : ±¹°¡º° Ŭ·¯½ºÅͺ°(2023-2032³â)
- Ŭ·¯½ºÅÍ Å×À̺íÀ» Àд ¹æ¹ý
- ¼ýÀÚ°¡ ÀǹÌÇÏ´Â °Í
- Ŭ·¯½ºÅÍ °£ÀÇ ¿µÇâ(ÀÚ¿ø ÇÒ´ç ¹æ¹ý)
- À§Çè°ú KPI ¿öÄ¡¸®½ºÆ®
- ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå : ÀÓ»ó ¿µ¿ªº°(2023-2032³â)
- ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå : ¸ð´Þ¸®Æ¼º°(2023-2032³â)
- ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå : ¼öÀÍ¿øº°(2023-2032³â)
- ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå : ÀÓ»ó ¿ëµµº°(2023-2032³â)
- ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå : ÃÖÁ¾ ¿ëµµ Á¶Á÷º°(2023-2032³â)
- ¶óƾ¾Æ¸Þ¸®Ä« ½ÃÀå : AI ±â¼úº°(2023-2032³â)
¼½¼Ç 5-MARKINTEL ¼Ö·ç¼Ç äÅà ¹× ¼ºÀå ¸ÅÆ®¸¯½º-¶óƾ¾Æ¸Þ¸®Ä«
- »çºÐ¸é ºÐ¼®
- Å©·Î½º Äõµå·±Æ® ¿î¿ë ·Îµå¸Ê
¼½¼Ç 6-MARKINTEL »ýŰè Çù¾÷ ¸ÅÆ®¸¯½º-¶óƾ¾Æ¸Þ¸®Ä«
- »çºÐ¸é ºÐ¼®
- ¿î¿ë ·Îµå¸Ê(90Àϰ£ ÁýÁß)
- KPI ¿öÄ¡¸®½ºÆ®
¼½¼Ç 7-GTM °³¿ä-¶óƾ¾Æ¸Þ¸®Ä«
- GTM Áغñ ·¹ÀÌ´õ-¶óƾ¾Æ¸Þ¸®Ä«
- GTM ŸÀÓ¶óÀÎ-¶óƾ¾Æ¸Þ¸®Ä«
- ¶óƾ¾Æ¸Þ¸®Ä« ±¹°¡ Ŭ·¯½ºÅÍ ¿ä¾à
- Ŭ·¯½ºÅÍ ¿ì¼±¼øÀ§ È÷Æ®¸Ê
- ±ÔÁ¦ ¼Óµµ¿Í »óȯ µ¿Çâ-¶óƾ¾Æ¸Þ¸®Ä«
- OEM AI ºÎÂøÀ²-¶óƾ¾Æ¸Þ¸®Ä«
- ±â¾÷º° GTM ¼º¼÷µµ ÇÏÀ̶óÀÌÆ®-¶óƾ¾Æ¸Þ¸®Ä«
- Á¶´Þ ¹× È£½ºÆÃ-Ŭ¶ó¿ìµå ¹× µ¥ÀÌÅÍ ·¹Áö´ø½Ã Äݾƿô
AJY 25.08.27
Report Metadata
- Geographic scope: Latin America (Brazil; Mexico; Chile; Colombia; Argentina; Peru; Central America; Caribbean; other small states).
- Key numbers (LATAM): $120M (2023) -> $1.0B (2032); CAGR ~26.6%.
- Segmentation covered: Modalities (CT, MRI, X ray/DR, Ultrasound, PET/Nuclear); Clinical areas (Oncology, Neurology/Stroke, Cardiology, Respiratory/Lung, MSK/Ortho, General Diagnostic); Applications (Early detection/triage; Diagnostic accuracy; Workflow/efficiency; Prognosis/treatment; Image enhancement/dose; Segmentation/feature extraction; Integration across modalities); Revenue streams (Hardware; Software; Service; Cloud/Pay per Use); End use (Hospitals, Imaging centers, Clinics, Teleradiology, Other).
- Frameworks & visuals included: Solution Adoption & Growth Matrix, Ecosystem Collaboration Matrix, GTM Readiness Radar, GTM Timeline, Cluster Priority Heatmap, Regulatory Velocity & Reimbursement Pulse, OEM AI Attach Rate.
- Methodology & QA: Dual lens (top down funnel + bottom up attach rate), evidence confidence rubric, and QA loop (sum to total, scrape diff, freshness, ASP sanity).
The "LATAM - AI assisted Medical Imaging Market (Markintel-TM Pulse)" distills the region's demand signals, regulatory cadence, and attach rate economics into actionable GTM playbooks. It sizes the market and shows where-and how-to win using regional frameworks, country cluster forecasts, and evidence based recommendations.
Who should use this report:
- Imaging OEMs planning bundled CT/MR/X ray offers and attach rate strategies.
- AI pure plays & marketplace integrators seeking enterprise pilots and distributor routes.
- Teleradiology networks & private hospital groups optimizing workflow/QA and cloud OPEX.
- Investors & corporate development teams validating growth theses and partner screens.
- Public sector program leads (TB, stroke, screening) aligning tenders to evidence and infrastructure.
What you get (benefits):
- Clear line of sight from insight to action: dual lens methodology + QA loop ensure every table rolls to the regional total and every recommendation ties to evidence.
- Prioritized country cluster roadmap with dollarized breakouts and 12 month actions.
- Framework driven GTM: Solution Adoption & Growth Matrix and Ecosystem Collaboration Matrix translate market structure into partner, pricing, and deployment moves.
- Full segmentation (modality, clinical area, application, revenue stream, end use) with 2023-2032 forecasts for quick reuse in internal decks.
Inside the report (highlights by section):
- Section 1: Executive Summary-the 25 second read; region level KPIs; inflection points & watch outs; 12 month board level actions.
- Section 2: Research Methodology-scope, segmentation, dual lens architecture, evidence confidence, and QA.
- Section 3-4: Market Analysis & Forecasts-growth driver waterfall; unified cluster model; estimates by cluster, clinical area, modality, revenue stream, application, end use.
- Sections 5-7: GTM Tools-Solution Adoption & Growth Matrix; Ecosystem Collaboration Matrix; 90 day operating roadmap; GTM Readiness Radar; Timeline; regulatory velocity; OEM attach rate; vendor GTM highlights.
TABLE OF CONTENTS
SECTION 1 - EXECUTIVE SUMMARY
- Why LATAM Matters - The 25 second Read
- LATAM Outlook at a Glance (2023 -> 2032)
- Where Growth Concentrates - Modality & Clinical Mix (LATAM)
- Inflection Points & Watchouts - LATAM
- Competitive Heat - the Moves to Track (LATAM Lens)
- 12-Month Board-Level Actions (What to Do Now)
SECTION 2 - RESEARCH METHODOLOGY
- About This Pulse Report
- Scope & Segmentation
- Marketstrat "Insights -> Action"
- Dual lens Architecture (Regionalized)
- Evidence Confidence - LATAM
- Quality Assurance Loop
- Limitations & Mitigations (Regional)
- Regulatory & Privacy References Used in Sizing and GTM Guidance
SECTION 3 - LATIN AMERICAN (LATAM) MARKET ANALYSIS
- Market Summary
- Growth Driver Waterfall - LATAM
- Geo-Economic Clusters (for GTM Focus)
- Segment Trends to 2032
- Regulatory Snapshot (Big 5)
- What's New for 2024-25
- Action-Oriented Recommendations
- Commercial Signals
SECTION 4 - LATAM MARKET ESTIMATES & FORECASTS
- LATAM Market by Country Cluster (2023-2032)
- How to Read the Cluster Table
- What the Numbers Imply
- Cross Cluster Implications (How to Allocate Resources)
- Risk & KPI Watchlist
- LATAM Market by Clinical Area (2023-2032)
- LATAM Market by Modality (2023-2032)
- LATAM Market by Revenue Stream (2023-2032)
- LATAM Market by Clinical Application (2023-2032)
- LATAM Market by End-Use Organization (2023-2032)
- LATAM Market by AI Technology (2023-2032)
SECTION 5 - MARKINTEL SOLUTION ADOPTION & GROWTH MATRIX - LATAM
- Quadrants Analysis
- Cross-Quadrant Operating Roadmap (2024 27)
SECTION 6 - MARKINTEL ECOSYSTEM COLLABORATION MATRIX - LATAM
- Quadrants Analysis
- Operating Roadmap (90 Day Focus)
- KPI Watchlist
SECTION 7 - GTM AT-A-GLANCE - LATAM
- GTM Readiness Radar - LATAM
- GTM Timeline - LATAM
- LATAM Country Clusters Summary
- Cluster-Priority Heatmap
- Regulatory Velocity & Reimbursement Pulse - LATAM
- OEM AI Attach Rate - LATAM
- GTM Maturity Highlights by Company - LATAM
- Procurement & Hosting - Cloud/Data Residency Callout